摘要
目的系统评价刮痧疗法对偏头痛患者的临床有效性及安全性。方法系统检索中国知网、万方数据知识服务平台、维普网、中国生物医学文献数据库、PubMed、Cochrane Library、Embase、Web of Science等数据库中关于刮痧治疗偏头痛的临床随机对照研究,检索时限为2013年1月—2025年1月。提取有效率、头痛证候积分、头痛程度等结局指标,采用RevMan 5.4软件进行Meta分析。结果最终纳入6篇文献共384例患者。Meta分析结果显示,刮痧疗法总有效率高于对照组[OR=4.48,95%CI(2.17,9.22),P<0.0001];试验组头痛证候积分低于对照组[MD=−1.49,95%CI(−2.37,−0.61),P=0.0009];刮痧可减轻头痛程度[SMD=−1.41,95%CI(−1.78,−1.04),P<0.00001]并缩短头痛持续时间[SMD=−8.94,95%CI(−13.47,−4.42),P=0.0001],同时改善患者生活质量及负性情绪,且短期无严重不良反应。结论刮痧对偏头痛具有一定疗效及安全性,但受限于纳入研究数量与质量,结论需多中心、大样本RCT进一步验证。
Objective To systematically evaluate the clinical efficacy and safety of Gua Sha therapy in patients with migraine.Methods Clinical randomized controlled trials(RCTs)of Gua Sha in treatment of migraine patients were systematically retrieved from databases such as CNKI,Wanfang Data Knowledge Service Platform,VIP,China Biology Medicine disc,PubMed,Cochrane Library,Embase,and Web of Science,which had been published between January 2013 and January 2025.Outcome indexes such as effectiveness rate,headache symptom score,and headache intensity were extracted,and a meta-analysis was performed by using RevMan 5.4 software.Results Six articles involving 384 patients were finally included.Meta-analysis showed that the total effectiveness rate of Gua Sha therapy was higher than that of the control group[OR=4.48,95%CI(2.17,9.22),P<0.0001].The headache symptom score in experimental group was lower that of the control group[MD=−1.49,95%CI(−2.37,−0.61),P=0.0009].Gua Sha therapy could reduce headache intensity[SMD=−1.41,95%CI(−1.78,−1.04),P<0.00001]and shortened headache duration[SMD=−8.94,95%CI(−13.47,−4.42),P=0.0001],while it could simultaneouly improve patients'quality of life and negative emotions without severe adverse reactions in the short term.Conclusions Gua Sha therapy has a certain efficacy and safety in treatment of patients with migraine,but the conclusion needs to be further verified by multi-center and large-sample RCTs due to the limited quantity and quality of included studies.
作者
符路路
蔡圣年
陶清
张传英
FU Lulu;CAI Shengnian;TAO Qing;ZHANG Chuanying(College of Modern Recreation Industry,Anhui Sanlian University,Hefei,Anhui 230601,China;Department of Acupuncture and Massage,The First Affiliated Hospital of Anhui University of Chinese Medicine,Hefei,Anhui 230031,China;Nursing College,Anhui University of Chinese Medicine,Hefei,Anhui 230012,China)
出处
《医药前沿》
2025年第25期18-22,共5页
Journal of Frontiers of Medicine
基金
安徽三联学院校级自然科学研究一般项目(KJYB2025013)
安徽省高校优秀青年骨干教师国内访问研修项目(gxgnfx2021168)。
